NMDA Antagonisten
European patent · EP0624569 · Deleted
Register entry
- Publication number
- EP0624569
- Application number
- EP94110261
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Feb 24, 1992
- Published
- Nov 17, 1994
- Granted
- Jul 29, 1998
- Deleted
- Feb 23, 2012
- Reason
- Maximum term reached
- IPC classes
- C07C 229/42 (2006.01)A61K 31/405 (2006.01)A61K 31/19 (2006.01)
- Priority
- US 662670 28.02.1991
- Divided from
- EP92103066
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Feb 27, 2012
Maximum term reached
Published in Swissreg on 27.02.2012
- Oct 15, 2007
Address changed
- Representative
- E. Blum & Co. Patentanwälte, Am Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich
Published in +pat+ No 19 in 2007
- Feb 28, 2006
Transferred
- Owner
- MERRELL PHARMACEUTICALS INC., 2110 East Galbraith Road,, P.O. Box 156300, Cincinnati,, Ohio 45215-6300, USA → Aventis, Inc., 300 Somerset Corporate Boulevard, Bridgewater, NJ 08807, USA
Published in +pat+ No 4 in 2006
- Nov 30, 1998
Agent entered
- Representative
- E. Blum & Co. Patentanwälte, Am Vorderberg 11, 8044 Zürich
Published in PIDTJ No 22 in 1998
- Aug 14, 1998
Granted
Published in PIDTJ No 15 in 1998
Parties
Inventor
Palfreyman, Michael G.
CIncinnati, Ohio 45249, US
Salituro, Francesco G.
Fairfield, Ohio 45014, US
McDonald, Ian A.
Loveland, Ohio 45140, US
Schwarcz, Robert
Baltimore, Maryland 21209, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.